← Back to Search

Technology-Enabled Skin Cancer Screening for Stem Cell Transplant Survivors

N/A
Recruiting
Led By Saro H Armenian
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have undergone autologous or allogeneic hematopoietic stem cell transplantation (HCT) at City of Hope (COH)
Are 2 years (yrs) to 5 yrs (+/- 3 months [m]) after HCT
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Study Summary

This trial is testing the impact of an invention for early detection of skin cancer in stem cell transplant survivors and their primary care providers.

Who is the study for?
This trial is for stem cell transplant survivors who are 2-5 years post-transplant, can read and write in English or Spanish, have seen a primary care provider recently or plan to within a year, and can receive text messages. Those with active cancer or acute illness that limits participation cannot join.Check my eligibility
What is being tested?
The TEACH Study tests a 12-month program aimed at early skin cancer detection in stem cell transplant survivors. It includes education for both patients and doctors, questionnaires, computer tools, dermatoscopes for skin examination, and follow-up via text messaging.See study design
What are the potential side effects?
Since this study involves educational interventions rather than medications or invasive procedures, traditional side effects are not expected. However, participants may experience anxiety or stress related to increased vigilance about their health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had a stem cell transplant at City of Hope.
Select...
I had a stem cell transplant between 2 and 5 years ago.
Select...
I can fluently read and write in English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Downstream costs
Economic impact on patients - cost-effectiveness analysis
Economic impact on patients - sensitivity analysis
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Group III (PAE, physician, dermatoscope)Experimental Treatment6 Interventions
Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. Participants' physician receives a letter that describes the educational intervention and encourages them to do a skin examination at next patient visit. Physicians also receive a free dermatoscope with instructions for uploading images of suspect lesions and attend a 30-minute online course comprising additional descriptions of dermoscopic images for skin cancers and "mimickers" common in hematopoietic stem cell transplantation patients, along with clear instructions for using a dermatoscope and steps to integrate dermoscopy into their practice.
Group II: Group II (PAE, physician)Experimental Treatment4 Interventions
Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. Participants' physician receives a letter that describes the educational intervention and encourages them to do a skin examination at next patient visit.
Group III: Group I (PAE)Experimental Treatment3 Interventions
Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months.

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
561 Previous Clinical Trials
1,917,532 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,926,627 Total Patients Enrolled
Saro H ArmenianPrincipal InvestigatorCity of Hope Comprehensive Cancer Center
3 Previous Clinical Trials
746 Total Patients Enrolled

Media Library

Educational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04358276 — N/A
Skin Cancer Clinical Trial 2023: Educational Intervention Highlights & Side Effects. Trial Name: NCT04358276 — N/A
Educational Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04358276 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been recruited to take part in this experiment?

"Indeed, the clinicaltrials.gov database suggests that this research is actively looking for volunteers. The trial was initially published on October 30th 2020 and its information has since been updated on May 23rd 2022. 720 participants are needed from a single site to fulfill their quota."

Answered by AI

Is there currently a call for volunteers for this research project?

"Affirmative, clinicaltrials.gov attests to the ongoing recruitment for this trial which was inaugurated on October 30th 2020 and most recently refreshed on May 23rd 2022. To date, a total of 720 patients have need to be enrolled from 1 medical facility."

Answered by AI
~105 spots leftby Oct 2024